Location of Repository

The complexities of breast cancer desmoplasia

By Rosemary A. Walker

Abstract

Also available via http://breast-cancer-research.com/content/3/3/143The stromal, or ‘desmoplastic’, responses seen histologically in primary breast carcinomas can vary from being predominantly cellular (fibroblasts/myofibroblasts) with little collagen to being a dense acellular tissue. The mechanisms underlying the stromal response are complex; paracrine activation of myofibroblasts by growth factors is important but the contribution of cytokines/chemokines should not be ignored. A recent xenograft study has proposed that platelet-derived growth factor (PDGF) is the\ud initiator of the desmoplastic response, but this has not been confirmed by (limited) analyses in vivo. Further studies are required to elaborate the mechanisms of the desmoplastic response, to determine its role in breast cancer progression and whether it is the same for all carcinomas

Publisher: Biomed Central
Year: 2001
OAI identifier: oai:lra.le.ac.uk:2381/164
Journal:

Suggested articles

Preview

Citations

  1. (1999). A: Multiple chemotactic factors: fine control or redundancy? Trends Pharmacol Sci doi
  2. (1998). Baak JPA: Expression of growth factors, growth-inhibiting factors and their receptors in invasive breast cancer. I. An inventory in search of autocrine and paracrine loops. doi
  3. (1998). Baak JPA: Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II. Correlations with proliferation and angiogenesis. doi
  4. (1998). Brigstock DR: Characterization of cell associated and soluble forms of connective tissue growth factor produced by fibroblast cells in vitro. Growth Factors doi
  5. (1996). Cellular changes involved in the conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev
  6. (1990). Chambon P: A novel metalloproteinase gene specificity expressed in stromal cells of breast carcinomas. doi
  7. (1992). Dearing SJ: Transforming growth factor β1 expression in in-situ and invasive breast cancers. doi
  8. (1999). Different patterns of angiogenesis in sarcomas and carcinomas. Clin Cancer Res
  9. (1980). Heterotransplants of human tumours in nude mice. Antibiot Chemother doi
  10. (1987). Lipmann ME: Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 β-estradiol or vH-ras oncogene. doi
  11. (1981). Palshof T: Histopathological characteristics and oestrogen receptor content in primary breast carcinoma. Virchows Arch doi
  12. (1999). RA: Expression of MMP-2 and MMP9, their inhibitors and the activator MT1-MMP in primary breast carcinomas. doi
  13. (1994). Relationship of transforming growth factor β1 to extracellular matrix and stromal infiltrates in invasive breast carcinomas. doi
  14. (2000). SH: Human breast carcinoma desmoplasia is PDGF initiated. Oncogene doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.